Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00415077 · ClinicalTrials.gov registry record · NA
A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia
A NA study, sponsored by Walter Reed Army Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 960
- Enrollment target
NCT00415077 is a NA study that was terminated before completion, run by Walter Reed Army Medical Center. The registered enrollment target is 960 participants.
The verdict
NCT00415077, a NA study, was terminated before completion, sponsored by Walter Reed Army Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 960 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether there is a significant difference in visual outcomes or corneal haze after surface ablation for moderate and high myopia in active duty service members treated with PRK, Mitomycin-C (MMC) PRK and LASEK.
Interventions
- PROCEDURE PRK
- PROCEDURE MMC PRK
- PROCEDURE LASEK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2004-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00415077
The ClinicalTrials.gov registry entry for NCT00415077 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PRK is the first listed.
NCT00415077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00415077 about?
NCT00415077 is a clinical study titled "A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia". The purpose of this study is to assess whether there is a significant difference in visual outcomes or corneal haze after surface ablation for moderate and high myopia in active duty service members treated with PRK, Mitomycin-C (MMC) PRK and LASEK.
What is the current status of trial NCT00415077?
This trial is currently terminated. It is a NA study. The enrollment target is 960 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00415077?
The interventions under investigation include: PRK (PROCEDURE), MMC PRK (PROCEDURE), LASEK (PROCEDURE).
Who is sponsoring clinical trial NCT00415077?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.